LI
CMD

Leap Investments’s Cantel Medical Corporation CMD Stock Holding History

Leap Investments’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$354K Buy
+8,000
New +$298K 0.23% 165

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Leap Investments's CMD Position: Q2 2020 in Review

Leap Investments opened a new position in Cantel Medical Corporation (CMD) in Q2 2020: 8,000 shares worth $354K. The stake represents 0.23% of the portfolio and ranks #165 among its holdings.

210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Leap Investments held 8,000 shares of Cantel Medical Corporation worth $354K as of Q2 2020.
  • Cantel Medical Corporation was a new Leap Investments position in Q2 2020.
  • Cantel Medical Corporation made up 0.23% of Leap Investments's portfolio in Q2 2020, its #165 holding.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.